Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Cocaine Use Reduction With Buprenorphine

ClinicalTrials.gov ID: NCT01402492

Public ClinicalTrials.gov record NCT01402492. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 12:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Cocaine Use Reduction With Buprenorphine (CURB)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The aim of this study is to investigate the safety and effectiveness of buprenorphine in the presence of naltrexone for the treatment of cocaine dependence.

Study identification

NCT ID
NCT01402492
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Enrollment
302 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2011 (Type not available)
Primary completion
Jan 2013 (Actual)
Completion
Mar 2013 (Actual)
Last update posted
Oct 29, 2021

2011 – 2013

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
UCLA Integrated Substance Abuse Programs (ISAP) Los Angeles California 90025 —
Bay Area Addiction Research and Treatment (BAART) San Francisco California 94102 —
Addiction Research and Treatment Services (ARTS) Denver Colorado 80206 —
Howard University Hospital Washington D.C. District of Columbia 20060 —
Atlanta VA Medical Center Atlanta Georgia 30345 —
Bellevue Hospital Center New York New York 10016 —
Albert Einstein College of Medicine - Division of Substance Abuse The Bronx New York 10461 —
Maryhaven Columbus Ohio 43207 —
CODA, Inc. Portland Oregon 97214 —
South Texas Veterans Health Care System San Antonio Texas 78229 —
Recovery Centers of King County (RCKC) Seattle Washington 98122 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01402492, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2021 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01402492 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →